|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02185 BIOHEART-B
Nominal 
1.880 -0.030 (-1.571%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (49,028) | (140,616) | (88,471) | (48,494) |
| Net Cash from / (used in) Investing Activities | -- | (28,856) | (100,686) | (33,732) | (225,151) |
| Net Cash from / (used in) Financing Activities | -- | (5,819) | (35,178) | 383,680 | 722,993 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (83,703) | (276,480) | 261,477 | 449,348 |
| Cash & Cash Equivalents at beginning of period | -- | 451,318 | 708,531 | 453,667 | 20,672 |
| Effect of Foreign Exchange Rate Changes | -- | 1,823 | 19,267 | (6,613) | (16,353) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 369,438 | 451,318 | 708,531 | 453,667 |
| Remarks: | Real time quote last updated: 01/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -25,830,000 |
| %Change | -70.030% |
| EPS / (LPS) | RMB -0.110 |
| NBV Per Share (¥) | RMB 2.962 |